ABT: Abbott Laboratories Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ABT: Abbott Laboratories

ABT 124.51

-1.7%

3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: HerbVic	9/16/2003 3:47:40 PM
	of 33

HIV drug Kaletra proves effective in 5-year study September 16, 2003 BY FRANCINE KNOWLES Business Reporter Patients using Abbott Laboratories' HIV treatment drug Kaletra achieved and maintained undetectable levels of the virus in a five-year study and didn't develop resistance to treatment. The data demonstrate that undetectable virus levels can be maintained when Kaletra is given in combination with two other HIV drugs, North Chicago-based Abbott said in releasing the study Monday at a conference of the American Society of Microbiology in Chicago. The study of 100 patients showed that of the 68 patients who remained on the treatment for 252 weeks and took the medication as an initial treatment, 67 had undetectable levels of the virus. <snip> suntimes.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next